Mark Woodward's Publications

About Mark Woodward's Publications

Senior Professorial Fellow, Professorial Unit
  • Chair of Statistics, Epidemiology and Women’s Health at Imperial College London
  • Professor of Medical Statistics, Faculty of Medicine, UNSW Sydney
  • PhD ,
  • FMedSci,
  • FAHMS,
  • FESC

  • OS 05-01 PROX1 GENE CC GENOTYPE AS A MAJOR DETERMINANT OF EARLY ONSET OF T2D AND CARDIOVASCULAR COMPLICATIONS IN SLAVIC SUBJECTS FROM ADVANCE STUDY

    Journal of Hypertension Date published:

  • Obesity Severity and Duration Are Associated With Incident Metabolic Syndrome: Evidence Against Metabolically Healthy Obesity From the Multi-Ethnic Study of Atherosclerosis

    The Journal of Clinical Endocrinology & Metabolism Date published:

  • Reduced blood pressure after smooth muscle EFNB2 deletion and the potential association of EFNB2 mutation with human hypertension risk

    European Journal of Human Genetics Date published:

  • On validation of cardiovascular risk scores

    BMJ Date published:

  • Variation in hospital performance for heart failure management in the National Heart Failure Audit for England and Wales

    Heart Date published:

  • Adiposity in relation to age at menarche and other reproductive factors among 300 000 Chinese women: findings from China Kadoorie Biobank study

    International Journal of Epidemiology Date published:

  • Feasibility work to inform the design of a randomized clinical trial of wound dressings in elective and unplanned abdominal surgery

    British Journal of Surgery Date published:

  • ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease

    JAMA Internal Medicine Date published:

  • Gender Inequalities in Cardiovascular Disease Prevention and Management in Australian Primary Health Care: Results from the TORPEDO Study

    Heart, Lung and Circulation Date published:

  • Strategies to meet the need for long-term data

    Journal of Hypertension Date published:

  • Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents

    The Lancet Date published:

  • Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality

    Heart Date published:

  • Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes

    Diabetes Care Date published:

  • Abstract

    eLife Date published:

  • Estimated GFR and the Effect of Intensive Blood Pressure Lowering After Acute Intracerebral Hemorrhage

    American Journal of Kidney Diseases Date published:

  • Prognostic Significance of Hyponatremia in Acute Intracerebral Hemorrhage: Pooled Analysis of the Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial Studies*

    Critical Care Medicine Date published: